| Literature DB >> 12963725 |
Tong-Shin Chang1, Myung Jin Kim, Kanghyun Ryoo, Jihyun Park, Soo-Jung Eom, Jaekyung Shim, Keiichi I Nakayama, Keiko Nakayama, Motowo Tomita, Katsuhiko Takahashi, Min-Jae Lee, Eui-Ju Choi.
Abstract
p57KIP2, a member of the Cip/Kip family of enzymes that inhibit several cyclin-dependent kinases, plays a role in many biological events including cell proliferation, differentiation, apoptosis, tumorigenesis and developmental changes. The human p57KIP2 gene is located in chromosome 11p15.5, a region implicated in sporadic cancers and Beckwith-Wiedemann syndrome. We here report that p57KIP2 physically interacts with and inhibits c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK). The carboxyl-terminal QT domain of p57KIP2 is crucial for the inhibition of JNK/SAPK. Overexpressed p57KIP2 also suppressed UV- and MEKK1-induced apoptotic cell death. p57KIP2 expression during C2C12 myoblast differentiation resulted in repression of the JNK activity stimulated by UV light. Furthermore, UV-stimulated JNK1 activity was higher in mouse embryonic fibroblasts derived from p57-/- mice than in the cells from wild-type mice. Taken together, these findings suggest that p57KIP2 modulates stress-activated signaling by functioning as an endogenous inhibitor of JNK/SAPK.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12963725 DOI: 10.1074/jbc.M309421200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157